Vylor’s board authorized a $3 billion share repurchase program Oct. 22, giving the newly independent seed and genetics company authority to buy shares without announcing when purchases might start.
The authorization began immediately and has no expiration date. Vylor described the program as spanning multiple years. The company may acquire shares through market trading or private arrangements. Management said it would weigh the share price, economic conditions, legal requirements and competing capital priorities, including growth, dividends and acquisitions.
Vylor said the authorization was consistent with the capital-allocation strategy it presented at its Sept. 15 Investor Day. CEO Chuck Magro said the program reflected “confidence in Vylor’s future and the strength of our balance sheet and cash flow.”
Vylor’s Oct. 13 SEC filing said a court issued a temporary restraining order on Oct. 9 barring dividend payments and share repurchases, then stayed it Oct. 10 while an emergency motion and appeal proceeded. The filing said the court relied on Vylor’s representation that it did not intend to declare dividends or repurchase shares while the motion was pending. It said the motion and appeal remained pending as of Oct. 13. Vylor separately announced a quarterly dividend in a release on Oct. 22.
Vylor became an independent, publicly traded company after separating from Corteva on Oct. 1. On that date, 15 states and one sovereign brought litigation challenging the separation and seeking injunctive relief, according to Vylor’s filing. The court order recounted plaintiffs’ concern that assets could be depleted while claims involving historical PFAS liabilities remained unresolved. Vylor said it contests the claims and intends to defend itself.
The buyback release does not say when Vylor might begin purchases or how much of the authorization it will use. The company plans to release third-quarter results after the market closes Nov. 11 and hold a live webcast Nov. 12 at 9 a.m. ET.
